News
Genetix raises $35m for gene therapy work - The Boston Globe
archive.boston.com
Genetix's chief executive, Alfred Slanetz, is leaving the firm. Gene therapies, which typically use viruses to deliver healthy genes into cells to ...
Geneius Biotechnology $3.10 million Financing. Alfred Slanetz...
www.newslocker.com
OctaFinance.com
Geneius Biotechnology $3.10 million Financing. Alfred Slanetz Submitted Jun OctaFinance.com
Geneius Biotechnology, Inc., Corporation...
State should add incentives for regional school districts - The...
archive.boston.com
... a $2.3 million Proposition property tax override targeted for its schools. As Cohasset School Committee member Alfred Slanetz told the Globe,
Event: Family Office & Private Wealth Management Qwotedapp.qwoted.com › opportunities
app.qwoted.com
Alfred E. Slanetz, Ph.D., President & CEO, Geneius Biotechnology, Inc. Michael Pompian, Founder and CIO, Sunpointe Investments (MFO). Thomas Frei,
sorted by relevance / date